The increase in ADHD diagnoses contributes to Adderall deficiency
In October 2022, the FDA announced a shortage of dextroamphetamine/amphetamine (Adderall; Teva Pharmaceuticals Industries Ltd),1 a common stimulant prescribed to people with attention deficit hyperactivity disorder (ADHD). Characterized by impulsivity, …
The increase in ADHD diagnoses contributes to Adderall deficiency Read More